Provided by Tiger Fintech (Singapore) Pte. Ltd.

Minerva Neurosciences

1.54
-0.0916-5.62%
Volume:5.36K
Turnover:8.37K
Market Cap:10.76M
PE:1.88
High:1.70
Open:1.70
Low:1.52
Close:1.63
Loading ...

Minerva Neurosciences Q1 EPS $(0.50) Beats $(1.07) Estimate

Benzinga
·
13 May

BRIEF-Minerva Neurosciences Q1 Net Income USD -3.753 Million

Reuters
·
13 May

Minerva Neurosciences Q1 Basic EPS USD -0.5

THOMSON REUTERS
·
13 May

Minerva Neurosciences Q1 Operating Expenses USD 3.903 Million

THOMSON REUTERS
·
13 May

Minerva Neurosciences Q1 EPS USD -0.5

THOMSON REUTERS
·
13 May

Minerva Neurosciences Inc expected to post a loss of $1.07 a share - Earnings Preview

Reuters
·
25 Apr

Minerva Neurosciences Reports Improved 2024 Financials

TIPRANKS
·
06 Mar

Minerva Neurosciences Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
26 Feb

Hold Rating for Minerva Neurosciences Amidst Uncertainty Over Roluperidone and Financial Constraints

TIPRANKS
·
26 Feb

Minerva Neurosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
25 Feb

Minerva Neurosciences: Q4 Earnings Snapshot

Associated Press Finance
·
25 Feb

Minerva Neurosciences Q4 2024 GAAP EPS $(0.56) Beats $(1.05) Estimate, Cash, Cash Equivalents And Restricted Cash At December 31, 2024, Were Approximately $21.5M

Benzinga
·
25 Feb

BRIEF-Minerva Neurosciences Q4 Net Income USD -4.272 Million

Reuters
·
25 Feb

Minerva Neurosciences Q4 Income From Operations USD -4.522 Million

THOMSON REUTERS
·
25 Feb

Minerva Neurosciences Q4 Basic EPS USD -0.56

THOMSON REUTERS
·
25 Feb

Minerva Neurosciences Q4 Operating Expenses USD 4.522 Million

THOMSON REUTERS
·
25 Feb

Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates

GlobeNewswire
·
25 Feb

Minerva Neurosciences Inc expected to post a loss of $1.05 a share - Earnings Preview

Reuters
·
18 Feb